TVGN

Tevogen Bio Holdings (TVGN)

About Tevogen Bio Holdings (TVGN)

Tevogen Bio Holdings, Inc. is a clinical-stage specialty immunotherapy company, which engages in the provision of off-the-shelf therapies for the treatment of infectious diseases, cancers, and neurological disorders. It focuses on its product, ExacTcell, a technology that treats acute viral infections, long-term consequences of viral infections, and viral and non-viral induced cancers. The company was founded in April 2021 and is headquartered in Warren, NJ.

Details

Daily high
$10.32
Daily low
$9.32
Price at open
$9.54
52 Week High
$71.00
52 Week Low
$4.14
Market cap
38.3M
Dividend yield
0.00%
Volume
6,949
Avg. volume
36,496
P/E ratio
-1.57

Tevogen Bio Holdings News

Details

Daily high
$10.32
Daily low
$9.32
Price at open
$9.54
52 Week High
$71.00
52 Week Low
$4.14
Market cap
38.3M
Dividend yield
0.00%
Volume
6,949
Avg. volume
36,496
P/E ratio
-1.57